People who have Diabetes and are on insulin often undergo pain due to needle pricks to administer insulin. Although insulin pumps have brought immense relief in this matter, researchers are looking for ways to ease the life of people with Diabetes by finding an effective medication.Insulin icodec is newer basal insulin which could be administered once in a week. The phase 2 trial, published in The New England Journal of Medicine, was conducted on 247 participants who were not on insulin previously and they were divided into two groups.The HbAlc of the participants was 7-9.5 per cent. One group received icodec once-weekly injection whereas the other group was administered with once-daily long-acting insulin glargine u 100. Mer 26 weeks of administration. the HbA le of people in the icodec group was lowered by 1.33 per cent whereas the glargine group had a 1.15 per cent decrease in their HbAlc. Other conditions such as hypoglycaemia and cognitive impairment were found to be low in both groups. The study has concluded that the effect of both medications on people with Type 2 Diabetes was the same.Glucagon-like peptide-1 receptor agonists (GLP-1) or incretin mimetics are a class of drugs that are used to control blood sugar levels. These short-acting drugs work by slowing down gastric emptying after a meal, promoting insulin secretion and reducing the secretion of glucose in the liver. A recent research study published in the journal Diahetologia has found that GLP-1 receptor agonist dulaglutide helps reduce liver fat in people with non-alcoholic fatty liver disease.The study was conducted on 52 people in India with Type 2 Diabetes and 6 percent or more of liver fat. They were administered with dulaglutide once in a week for 24 weeks. The outcomes have shown that dulaglutide led to a reduction of liver fat by 5.5 per cent in 24 weeks. Long term administration of dulaglutide has been found to significantly lower the fat content in the liver. The drug was also found to lower HbAlc and body weight. Consult your physician to understand the right medication for you.
People who have Diabetes and are on insulin often undergo pain due to needle pricks to administer insulin. Although insulin pumps have brought immense relief in this matter, researchers are looking for ways to ease the life of people with Diabetes by finding an effective medication.Insulin icodec is newer basal insulin which could be administered once in a week. The phase 2 trial, published in The New England Journal of Medicine, was conducted on 247 participants who were not on insulin previously and they were divided into two groups.The HbAlc of the participants was 7-9.5 per cent. One group received icodec once-weekly injection whereas the other group was administered with once-daily long-acting insulin glargine u 100. Mer 26 weeks of administration. the HbA le of people in the icodec group was lowered by 1.33 per cent whereas the glargine group had a 1.15 per cent decrease in their HbAlc. Other conditions such as hypoglycaemia and cognitive impairment were found to be low in both groups. The study has concluded that the effect of both medications on people with Type 2 Diabetes was the same.Glucagon-like peptide-1 receptor agonists (GLP-1) or incretin mimetics are a class of drugs that are used to control blood sugar levels. These short-acting drugs work by slowing down gastric emptying after a meal, promoting insulin secretion and reducing the secretion of glucose in the liver. A recent research study published in the journal Diahetologia has found that GLP-1 receptor agonist dulaglutide helps reduce liver fat in people with non-alcoholic fatty liver disease.The study was conducted on 52 people in India with Type 2 Diabetes and 6 percent or more of liver fat. They were administered with dulaglutide once in a week for 24 weeks. The outcomes have shown that dulaglutide led to a reduction of liver fat by 5.5 per cent in 24 weeks. Long term administration of dulaglutide has been found to significantly lower the fat content in the liver. The drug was also found to lower HbAlc and body weight. Consult your physician to understand the right medication for you.
